Detail of the clinical trial

Title of the trial International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia
EudraCT number 2010-018980-41
Protocol number Pediatric_Relapsed_AML2010/01
Sponsor Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
Indications Hemato-oncology
Diagnosis Leukemia
Population in clinical trial Newborns (0-27 days)
Infants and Toddlers (28 days - 23 months)
Children (2-11 years)
Adolescents (12-17 years)
Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2013
Date of approval by Institute (SÚKL) 26.11.2013
Date of approval by EC 26.6.2013
Date of initiation CT in ČR
Date of ending CT in ČR 14.1.2020
Notice
Sites Fakultní nemocnice Olomouc, Klinika pediatrie, I.P.Pavlova 6, 775 20 Olomouc
Fakultní nemocnice Brno, Klinika dětské onkologie, Černopolní 9, 662 63 Brno
Fakultní nemocnice v Motole, Klinika dětské hematologie a onkologie, V Úvalu 84, 150 06 Praha 5 - Motol

‹‹ Back to list